Preparation and Application of two Monoclonal Antibodies against Canine Parvovirus Vaccine and Field Strains
Journal Title: Journal of Vaccines and Immunology - Year 2017, Vol 3, Issue 1
Abstract
Background: Canine parvovirus (CPV) emerged in 1970s as a highly infectious disease. CPV modified live vaccines have been widely used to control the disease. It is urgent to develop specific monoclonal antibodies to differentiate field virus from vaccine virus in vaccinated dogs. Methods: In this study, female BALB/C mice were immunized with a commercial CPV vaccine strain. Two monoclonal antibodies (MAbs) 10H4 and 10B11 were made by hybridoma technique, and screened by hemagglutination inhibition (HI) assay. Results: MAb 10H4 reacted with both CPV field and vaccine strains, and MAb 10B11 only recognized field but not vaccine strains by the results of HI, indirect immunofluorescence (IFA), and virus neutralization tests. Conclusion: Therefore, these two MAbs may work as useful tools to study the CPV pathogenic mechanisms and to develop diagnostic reagents.
Authors and Affiliations
Hao Liying, Wang Ying, Bai Chenyu, Jin Yudan, Zheng Dingding, Chen Lingyan, Li Xiangdong, Deng Junhua, Tian Kegong
Keywords
Related Articles
- EP ID EP553759
- DOI 10.17352/jvi.000020
- Views 60
- Downloads 0
Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating a...
Lethal Food-Induced Anaphylaxis in Children
Despite careful contributions, food allergic children have a significant risk of anaphylactic episodes. Especially at risk are children not accompanied by parents or caregivers in public places, or restaurants, or not pr...
The Role of Endoplasmic Reticulum Aminopeptidase 1 Biology in Immune Evasion by Tumours
Expression of MHC I at the cell surface is essential for presenting peptides to circulating cytotoxic T cells. Interference with a number of components of the antigen processing machinery is an immune evasion mechanism t...
IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses. Also, exper...
Immunogenicity of Hydrolysate Formulas in Children (Part 1). Review of 202 Reactions
Cow's milk (CM) protein hydrolyzed formulas (HFs) appeared in the 40's with the aim of decreasing or eliminating the allergenicity of CM proteins, and in addition of reducing the risk of sensitization. In recent years th...